...
首页> 外文期刊>Disease models & mechanisms: DMM >Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation
【24h】

Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation

机译:基质金属蛋白酶9,血管内皮生长因子和破骨细胞功能之间的互补相互作用驱动软骨内骨形成

获取原文
           

摘要

Long bone development depends on endochondral bone formation, a complex process requiring exquisite balance between hypertrophic cartilage (HC) formation and its ossification. Dysregulation of this process may result in skeletal dysplasias and heterotopic ossification. Endochondral ossification requires the precise orchestration of HC vascularization, extracellular matrix remodeling, and the recruitment of osteoclasts and osteoblasts. Matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEGF) and osteoclasts have all been shown to regulate endochondral ossification, but how their function interrelates is not known. We have investigated the functional relationship among these regulators of endochondral ossification, demonstrating that they have complementary but non-overlapping functions. MMP-9, VEGF and osteoclast deficiency all cause impaired growth plate ossification resulting in the accumulation of HC. VEGF mRNA and protein expression are increased at the MMP-9?/? growth plate, and VEGF activity contributes to endochondral ossification since sequestration of VEGF by soluble receptors results in further inhibition of growth plate vascularization and ossification. However, VEGF bioavailability is still limited in MMP-9 deficiency, as exogenous VEGF is able to rescue the MMP-9?/? phenotype, demonstrating that MMP-9 may partially, but not fully, regulate VEGF bioavailability. The organization of the HC extracellular matrix at the MMP-9?/? growth plate is altered, supporting a role for MMP-9 in HC remodeling. Inhibition of VEGF impairs osteoclast recruitment, whereas MMP-9 deficiency leads to an accumulation of osteoclasts at the chondro-osseous junction. Growth plate ossification in osteoclast-deficient mice is impaired in the presence of normal MMP-9 expression, indicating that other osteoclastic functions are also necessary. Our data delineate the complementary interplay between MMP-9, VEGF and osteoclast function that is necessary for normal endochondral bone formation and provide a molecular framework for investigating the molecular defects contributing to disorders of endochondral bone formation.
机译:长时间的骨骼发育取决于软骨内骨骼的形成,这是一个复杂的过程,需要在肥大性软骨(HC)的形成与其骨化之间取得精确的平衡。该过程的失调可能导致骨骼发育异常和异位骨化。软骨内骨化需要HC血管化的精确编排,细胞外基质重塑以及破骨细胞和成骨细胞的募集。基质金属蛋白酶9(MMP-9),血管内皮生长因子(VEGF)和破骨细胞均能调节软骨内骨化,但其功能如何相互关系尚不清楚。我们研究了这些软骨内骨化调节因子之间的功能关系,证明它们具有互补但不重叠的功能。 MMP-9,VEGF和破骨细胞缺乏都会导致生长板骨化受损,从而导致HC积累。 VEGF mRNA和蛋白表达在MMP-9α/β升高。由于可溶性受体螯合VEGF会进一步抑制生长板的血管化和骨化,因此VEGF的活性会促进软骨内的骨化。但是,由于MMP-9缺乏,VEGF的生物利用度仍然受到限制,因为外源性VEGF能够挽救MMP-9α/β。表型,表明MMP-9可能部分而非完全调节VEGF的生物利用度。 HC细胞外基质在MMP-9α/β上的组织。生长板发生改变,支持MMP-9在HC重塑中的作用。抑制VEGF会破坏破骨细胞募集,而MMP-9缺乏会导致破骨细胞在软骨-骨连接处积聚。在正常MMP-9表达的情况下,破骨细胞缺乏症小鼠的生长板骨化受到损害,表明其他破骨细胞功能也是必需的。我们的数据描述了正常软骨内骨形成所必需的MMP-9,VEGF和破骨细胞功能之间的互补相互作用,并为研究导致软骨内骨形成失调的分子缺陷提供了分子框架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号